Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
April 25, 2014 11:17 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Edwards Lifesciences (NYSE: EW) price target of $94.00 (from $72.00) following solid Q1 results.
Denhoy SAID, "1Q TAVR upside was fueled by notable strength in Europe... More
